Back to search

Article

Small Molecule Agonists of TREM2 Reprogram Microglia and Protect Synapses in Human Alzheimer’s Models

2026-01-21

Abstract excerpt

Triggering receptor expressed on myeloid cells-2 (TREM2) is a key immune receptor in the central nervous system that regulates microglial phagocytosis, survival, and neuroinflammatory responses. TRME2 variants have been established as genetic risk factors for Alzheimer’s disease (AD). However, the therapeutic development of TREM2 modulators has been limited to antibody-based approaches that face limitations in blo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a2df9b54-80a3-5696-b9a8-3b3f3f1f0c6f
DOI
10.64898/2026.01.19.700278
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Small Molecule Agonists of TREM2 Reprogram Microglia and Protect Synapses in Human Alzheimer’s ModelsDOI 10.64898/2026.01.19.700278
Select a neighboring publication to make it the new centre.